Effects of chemo-endocrine therapy on DMBA-induced rat mammary carcinoma
Yamamoto, H.; Morimoto, T.; Monden, A.
Nihon Geka Gakkai Zasshi 90(10): 1786-1792
1989
ISSN/ISBN: 0301-4894 PMID: 2512475 Document Number: 346849
Document emailed within 1 workday
Related Documents
Yamamoto, H.; Morimoto, T.; Monden, A. 1989: Effects of chemo-endocrine therapy on DMBA-induced rat mammary carcinoma Nihon Geka Gakkai Zasshi 90(10): 1786-1792Dias, M.; Cabrita, S.; Sousa, E.; França, B.; Patrício, J.; Oliveira, C. 1999: Benign and malignant mammary tumors induced by DMBA in female Wistar rats European Journal of Gynaecological Oncology 20(4): 285-288
Grinevich YuA; Kamenets LYa 1982: Potentiation of the thymosin immunoregulatory effect by hypocorticoidism in rats with DMBA-induced carcinogenesis in mammary glands Neoplasma 29(1): 19-27
Iino, Y.; Yamazaki, K.; Ogawa, T.; Hirai, T.; Arai, T.; Ishikawa, H.; Endo, K.; Kawai, T.; Izuo, M.; Takikawa, H. 1983: Effect of medroxyprogesterone acetate (MAP) and vitamin C on DMBA induced rat mammary cancer in relation to estrogen receptor(ER) Gan no Rinsho. Japan Journal of Cancer Clinics 29(9): 949-954
Quadri, S.K.; Kledzik, G.S.; Meites, J. 1974: Enhanced regression of DMBA-induced mammary cancers in rats by combination of ergocornine with ovariectomy or high doses of estrogen Cancer Research 34(3): 499-501
Sakamoto, S.; Kudo, H.; Suzuki, S.; Mitamura, T.; Sassa, S.; Kuwa, K.; Chun, Z.; Yoshimura, S.; Maemura, M.; Nakayama, T.; Shinoda, H. 1997: Additional effects of medroxyprogesterone acetate on mammary tumors in oophorectomized, estrogenized, DMBA-treated rats Anticancer Research 17(6d): 4583-4587
Taguchi, T. 1998: Adjuvant for breast cancer chemo-endocrine therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(4): 453-467
Itoh, J.; Nakagawa, H.; Sasaki, H.; Takahashi, T. 1985: A fibrin clot containing of anticancer drug for intra-arterial chemo-embolization therapy. (2) Chemotherapeutic effects on a model hepatoma using VX-2 carcinoma in rabbits Gan to Kagaku Ryoho. Cancer and ChemoTherapy 12(2): 258-264
Kitamura, M.; Tominaga, T.; Hayashi, K.; Takahashi, I.; Kosaki, G. 1985: Preliminary report of adjuvant chemo-endocrine therapy for breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 12(1): 111-117
Ikeda, T. 1994: "State of the art" of adjuvant chemo-endocrine therapy for breast cancer in Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(Suppl 3): 370-376
Kumamoto, Y.; Tsukamoto, T.; Umehara, T.; Shimazaki, J.; Fuse, H.; Ohshima, H.; Takeuchi, H.; Yoshida, O.; Okada, K.; Saito, Y. 1991: Clinical studies on endocrine therapy for prostatic carcinoma (4): Initial response to endocrine therapy and prognosis Hinyokika Kiyo. Acta Urologica Japonica 37(11): 1505-1510
Kawaguchi, T.; Mayama, I.; Iwabuchi, I.; Ogasawara, M.; Tsukui, A. 2010: Chemo-endocrine therapy with low-dose cisplatin, UFT, and dexamethasone for hormone-refractory prostate cancer patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(10): 1921-1925
Görlich, M. 1970: Endocrine characterization of mammary carcinoma Archiv für Geschwulstforschung 36(4): 385-393
Li, P.; Ge, H.-B.; Sun, Z. 2007: Inhibiting effects of GW2974 on DMBA-induced hamster buccal pouch carcinogenesis Zhonghua Kou Qiang Yi Xue Za Zhi 42(7): 432-435
Costlow, M.E.; Buschow, R.A.; Mcguire, W.L. 1976: Prolactin receptors in 7,12-dimethylbenz(a) anthracene-induced mammary tumors following endocrine ablation Cancer Research 36(11 Pt 1): 3941-3943
Kountouras, J.; Boura, P.; Karolides, A.; Zaharioudaki, E.; Tsapas, G. 1995: Recombinant a2 interferon (a-IFN) with chemo-hormonal therapy in patients with hepatocellular carcinoma (HCC) Hepato-Gastroenterology 42(1): 31-36
Abe, R.; Tsuchiya, A.; Koie, H.; Ono, K.; Abo, S.; Saito, K.; Tsukamoto, M.; Sato, T.; Mori, S.; Motoki, R. 1988: Cooperative research on post-operative adjuvant therapy of breast cancer. Tohoku Society of Adjuvant Chemo-endocrine Therapy of Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(9): 2707-2712
Costlow, M.E.; Buschow, R.A.; McGuire, W.L. 1976: Prolactin receptors and androgen-induced regression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma Cancer Research 36(9 Pt.1): 3324-3329
Senn, H.J. 1987: Current status of adjuvant chemo- and hormone therapy in resectable breast carcinoma Schweizerische Rundschau für Medizin Praxis 76(43): 1193-1199
Ankerst, J.; Steele, G.; Sjögren, H.O. 1974: Cross-reacting tumor-associated antigen(s) of adenovirus type 9-induced fibroadenomas and a chemically induced mammary carcinoma in rats Cancer Research 34(8): 1794-1800